Form 8-K - Current report:
SEC Accession No. 0001104659-25-052704
Filing Date
2025-05-27
Accepted
2025-05-27 07:00:31
Documents
12
Period of Report
2025-05-27
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2516117d1_8k.htm   iXBRL 8-K 24361
  Complete submission text file 0001104659-25-052704.txt   187745

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA btai-20250527.xsd EX-101.SCH 3047
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE btai-20250527_lab.xml EX-101.LAB 34239
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE btai-20250527_pre.xml EX-101.PRE 22380
14 EXTRACTED XBRL INSTANCE DOCUMENT tm2516117d1_8k_htm.xml XML 3562
Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Filer) CIK: 0001720893 (see all company filings)

EIN.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38410 | Film No.: 25984160
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)